Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

Reference Ranges and the Harmonization Problem

CDC HoSt, Travison 2017 Harmonized Ranges, and Cherry-Picked Cutoffs

Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.

The written rationale for this grade is still being prepared.

FDA
Reference ranges are lab/standards-body constructs, not FDA determinations

Reference only. Not medical advice.

What can go wrong

Adopting a clinic's elevated 'optimal' cutoff medicalizes normal physiology and exposes population-normal men to therapy risks (erythrocytosis, suppressed spermatogenesis, dependence) without guideline support. Mismatched, non-harmonized lab ranges also confuse longitudinal tracking.

This is something to take to a clinician. The Atlas can tell you what is known about reference ranges and the harmonization problem in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.

There is no single legislated 'normal' testosterone. Ranges historically differed by lab and assay, which the CDC HoSt program and the Travison et al. 2017 harmonized reference range project set out to fix by deriving standardized normative values from large cohorts of nonobese healthy young men. The harmonized work yielded a normal range with a lower limit around the mid-260s ng/dL (commonly cited ~264 ng/dL). Optimization clinics exploit the absence of a universal cutoff by adopting higher 'optimal' targets (often 600-1000+ ng/dL), so that men squarely within population-normal ranges are reclassified as candidates for therapy.

Move the line, make a patient: how clinics pick the cutoff that sells.

What people take it for

What it is taken for. Approval, where it exists, covers only some of these.

  • Interpreting whether a result is population-normal
  • Comparing results across standardized labs
  • Guideline-based diagnostic thresholds

How it works

Harmonization aligns assay output to a reference method (CDC HoSt) and then derives reference intervals from healthy-population data so a value means the same thing across labs. Travison et al. pooled cohorts to produce harmonized normative ranges by age. Diagnostic thresholds (e.g., the Endocrine Society's use of a lower limit near the mid-260s) flow from this work.

'Normal' vs 'optimal' is a marketing distinction

A man at 450 ng/dL is comfortably within harmonized population-normal ranges, but an optimization clinic targeting 800-1000 ng/dL can present him as deficient. The slide from a harmonized, evidence-based reference interval to an aspirational 'optimal' band is where commercial incentives enter. The Endocrine Society and AUA 2018 both anchor diagnosis to symptoms plus low measured testosterone against standardized ranges, not to a feel-better target a clinic invents.

What people get wrong

  • Often saidBelow 'optimal' means deficient

    Actually'Optimal' bands (often 600-1000+ ng/dL) are clinic-chosen marketing targets, not harmonized reference intervals. Population-normal includes values far below those numbers.

  • Often saidEvery lab's reference range is interchangeable

    ActuallyPre-harmonization ranges varied by lab and assay; only CDC HoSt-aligned, harmonized ranges are meant to be comparable.

Who profits, and who pushes back

  • Thomas Travison, PhD

    Pushes backLead author, 2017 harmonized reference ranges

    Harmonized ranges let a testosterone value be interpreted consistently rather than against an idiosyncratic local cutoff.

  • AUA Guideline Panel

    Pushes backAmerican Urological Association, 2018

    Low testosterone should be defined by repeated morning measurement below a standardized threshold, not by an arbitrary target.

What we do not know

  • How many optimization clinics publish their 'optimal' threshold versus letting it stay implicit?
  • How should age-specific harmonized ranges modify thresholds for older men?

At a glance

Harmonization project
Travison et al., 2017 (multi-cohort)
Standardization backbone
CDC HoSt certification
Commonly cited lower limit
~264 ng/dL (harmonized, nonobese 19-39 men)
Exploited gap
No single mandated cutoff; clinics set 'optimal' targets

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about Reference Ranges and the Harmonization Problem. A short entry is not a safe entry.

  • Timeline. We have not built the dated record of research and regulatory events.
  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • How it compares. We have not set it against the alternatives.
  • Children and teenagers. We have not checked what is known about younger people.
  • Where we land. We have not taken a position on this yet.

Sources

The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.

The studies that matter

  • Travison, Vesper, Orwoll et al.2017

    Derived harmonized reference ranges for total testosterone in nonobese healthy men 19-39; lower limit commonly cited near 264 ng/dL

  • AUA Testosterone Deficiency Guideline2018

    Used a total testosterone threshold of 300 ng/dL on two morning measurements to define low T

  • Endocrine Society guideline2018

    Anchored diagnosis to symptoms plus consistently low morning testosterone against a standardized range